187 related articles for article (PubMed ID: 17437038)
1. [Changes of vasoactive intestinal polypeptide and vasoactive intestinal polypeptide receptor 1 in small intestine and liver during macaque development].
Guo MM; Huang MH; Wang CH; Tang CW
Sheng Li Xue Bao; 2007 Apr; 59(2):163-8. PubMed ID: 17437038
[TBL] [Abstract][Full Text] [Related]
2. [Changes of somatostatin and expression of somatostatin receptor in small intestine and liver tissues during macaque development].
Guo MM; Tan QH; Fan H; Huang MH; Wang CH; Qiu XQ; Tang CW
Sheng Li Xue Bao; 2005 Dec; 57(6):719-24. PubMed ID: 16344896
[TBL] [Abstract][Full Text] [Related]
3. [The temporal and spatial distribution of vasoactive intestinal peptide and its receptor in the development of airway hyperresponsiveness].
Ren YH; Qin XQ; Guan CX; Luo ZQ; Zhang CQ; Sun XH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):224-8. PubMed ID: 15144609
[TBL] [Abstract][Full Text] [Related]
4. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial distribution of VIP, CGRP and their receptors in the development of airway hyperresponsiveness in the lungs.
Ren YH; Qin XQ; Guan CX; Luo ZQ; Zhang CQ; Sun XH
Sheng Li Xue Bao; 2004 Apr; 56(2):137-46. PubMed ID: 15127121
[TBL] [Abstract][Full Text] [Related]
7. Human hepatic progenitor cells express vasoactive intestinal peptide receptor type 2 and receive nerve endings.
Cassiman D; Sinelli N; Bockx I; Vander Borght S; Petersen B; De Vos R; van Pelt J; Nevens F; Libbrecht L; Roskams T
Liver Int; 2007 Apr; 27(3):323-8. PubMed ID: 17355452
[TBL] [Abstract][Full Text] [Related]
8. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis.
Kim DH; Park IH; Cho JS; Lee YM; Choi H; Lee HM
Am J Rhinol Allergy; 2011; 25(1):e44-7. PubMed ID: 21711977
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of vasoactive intestinal polypeptide in cultured myenteric neurons from adult rat small intestine.
Lin Z; Sandgren K; Ekblad E
Auton Neurosci; 2003 Aug; 107(1):9-19. PubMed ID: 12927222
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal polypeptide (VIP) and VPAC1 receptor in adult human dental pulp in relation to caries.
El Karim IA; Lamey PJ; Ardill J; Linden GJ; Lundy FT
Arch Oral Biol; 2006 Oct; 51(10):849-55. PubMed ID: 16806045
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of the VIP system in the gastro-intestinal tract of the Axolotl, Ambystoma mexicanum: successive appearance of co-existing PACAP and NOS.
Badawy G; Reinecke M
Anat Embryol (Berl); 2003 Mar; 206(4):319-25. PubMed ID: 12649730
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves.
Fahrenkrug J; Hannibal J; Tams J; Georg B
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1205-14. PubMed ID: 10950381
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative variation of vasoactive intestinal polypeptide and its receptor in rat liver during development].
Wang L; Tang CW; Wang CH; Li X
Sheng Li Xue Bao; 2005 Jun; 57(3):379-83. PubMed ID: 15968436
[TBL] [Abstract][Full Text] [Related]
14. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.
Xia M; Sreedharan SP; Bolin DR; Gaufo GO; Goetzl EJ
J Pharmacol Exp Ther; 1997 May; 281(2):629-33. PubMed ID: 9152366
[TBL] [Abstract][Full Text] [Related]
15. A light and electron microscopic immunohistochemical study of vasoactive intestinal polypeptide- and substance P-containing nerve fibers along the cerebral blood vessels: comparison with aminergic and cholinergic nerve fibers.
Itakura T; Okuno T; Nakakita K; Kamei I; Naka Y; Nakai K; Imai H; Komai N; Kimura H; Maeda T
J Cereb Blood Flow Metab; 1984 Sep; 4(3):407-14. PubMed ID: 6206080
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes.
Qian BF; Hammarström ML; Danielsson A
J Neuroendocrinol; 2001 Sep; 13(9):818-25. PubMed ID: 11578532
[TBL] [Abstract][Full Text] [Related]
17. [The expression and significance of VIP and its receptor in the cochlea of different degrees of chronic alcoholism rats].
Feng J; Liu H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 29(14):1295-8. PubMed ID: 26672247
[TBL] [Abstract][Full Text] [Related]
18. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
20. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
